Interactive program
Tuesday 21 March 2023
-
-
Welcome
Fabio S Taccone (Brussels, Belgium)
Jean-Louis Vincent (Brussels, Belgium)
-
-
Report of the Round Table conference: ICU populations: from syndromes to phenotypes
Carolyn S Calfee (San Francisco, United States)
Anthony Gordon (London, United Kingdom)
-
-
Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19
Ewan Goligher (Toronto, Canada)
-
-
Intravenous ravulizumab in mechanically ventilated patients hospitalized with severe COVID-19
Djillali Annane (Garches, France)
-
-
Hydrocortisone in severe community-acquired pneumonia
Nicholas Heming (Garches, France)
-
-
Early administration of prothrombin complex concentrate in trauma patients at risk of massive transfusion (PROCOAG)
Pierre Bouzat (Grenoble, France)
-
-
Tight glucose control in the absence of early parenteral nutrition
Jan Gunst (Leuven, Belgium)
-
-
Low versus standard calorie and protein feeding in ventilated adults with shock (NUTRIREA-3)
Jean Reignier (Nantes, France)
-
-
Max Harry Weil lecture: equity and equality in the ICU
Katarzyna Kotfis (Szczecin, Poland)
-
-
Hospital violence: critical care professionals at risk
Lewis J Kaplan (Philadelphia, United States)
DONATION AFTER CARDIAC DEATH
Paul H Mayo (New York, United States)
-
-
How to make it possible?
Marlies Ostermann (London, United Kingdom)
-
-
How ECMO can facilitate it
Rafael Badenes (Valencia, Spain)
-
-
How we do it
Jan Belohlavek (Prague, Czech Republic)
-
-
How we can improve it
Jacques Creteur (Brussels, Belgium)
-
-
Discussion
COVID-19: WHAT WE LEARNED
V Marco Ranieri (Bologna, Italy)
-
-
Immune profiling could identify severity
Nuala Meyer (Philadelphia, United States)
-
-
A better understanding of immunomodulation
Lieuwe Bos (Amsterdam, Netherlands)
-
-
The different responses to convalescent plasma therapy
Manu Shankar–Hari (Edinburgh, United Kingdom)
-
-
Discussion
-
-
It was different in children?
Adrienne Randolph (Boston, United States)
-
-
About the heterogeneity of myocarditis
Alain Combes (Paris, France)
-
-
How the epidemiology of bacterial infections has been affected
Matteo Bassetti (Genoa, Italy)
-
-
Discussion
-
-
About antivirals
Joost Wiersinga (Amsterdam, Netherlands)
-
-
About other ICU treatments
Anthony Gordon (London, United Kingdom)
-
-
Anti-C5a antibody was the best
Alexander Vlaar (Amsterdam, Netherlands)
-
-
Inhaled heparin as an option
Frank van Haren (Sidney, Australia)
-
-
Discussion
-
-
About stress, anxiety and burnout among the health care team
Michelle Chew (Linköping, Sweden)
-
-
About living guidelines
Janet Diaz (Geneva, Switzerland)
-
-
Is there still something to learn?
Tobias Welte (Hannover, Germany)
-
-
Discussion
SUBARACHNOID HEMORRHAGE
David Menon (Cambridge, United Kingdom)
-
-
Critical care management
Soojin Park (New York, United States)
-
-
A role for other medical therapies?
Georgia Tsaousi (Thessaloniki, Greece)
-
-
Can ROTEM help to predict cerebral ischemia?
Nicole Juffermans (Amsterdam, Netherlands)
-
-
Delayed cerebral ischemia: still a role for induced hypertension?
Walter van den Bergh (Groningen, Netherlands)
-
-
Discussion
-
-
Catheter-associated bloodstream infections
Philippe Eggimann (Lausanne, Switzerland)
-
-
Probiotics may decrease the risk of lung infection
Evangelos Giamarellos–Bourboulis (Athens, Greece)
-
-
Advanced airway devices to reduce risk of VAP
Paul Dark (Manchester, United Kingdom)
-
-
Other new approaches to VAP prevention
Philippe Montravers (Paris, France)
-
-
Discussion
-
-
SDD - here we go again?
Jan De Waele (Ghent, Belgium)
-
-
Why aren´t you using SDD?
Simon Finfer (Newtown, Australia)
-
-
Indications for antibiotic prophylaxis
Pedro Povoa (Lisbon, Portugal)
-
-
Discussion
-
-
Break
TRAUMATIC BRAIN INJURY
Soojin Park (New York, United States)
-
-
A very heterogeneous entity!
Marek Mirski (Baltimore, United States)
-
-
Different in pregnant patients?
Chiara Robba (Genoa, Italy)
-
-
How has outcome improved?
David Menon (Cambridge, United Kingdom)
-
-
Extreme therapies
Giuseppe Citerio (Monza, Italy)
-
-
Discussion
INTRACRANIAL HYPERTENSION
Chiara Robba (Genoa, Italy)
-
-
Current indications for ICP monitoring
Giuseppe Citerio (Monza, Italy)
-
-
Benefits and risks of hyperosmolar therapy
Marek Mirski (Baltimore, United States)
-
-
Is hypertonic lactate the solution?
Mauro Oddo (Lausanne, Switzerland)
-
-
Is hypertonic saline the solution?
Georgia Tsaousi (Thessaloniki, Greece)
-
-
Discussion
NEUROMONITORING
Mauro Oddo (Lausanne, Switzerland)
-
-
Pupil reactivity: the simplest method
Giuseppe Citerio (Monza, Italy)
-
-
Biomarkers
David Menon (Cambridge, United Kingdom)
-
-
Brain tissue oxygenation
Pierre Bouzat (Grenoble, France)
-
-
Discussion
-
-
Brain metabolic monitoring
Raimund Helbok (Linz, Austria)
-
-
Multimodal brain monitoring: EEG + Doppler + NIRS
André Denault (Montreal, Canada)
-
-
How I integrate it all
Geert Meyfroidt (Leuven, Belgium)
-
-
It´s not only a matter of thresholds
Soojin Park (New York, United States)
-
-
Discussion
-
-
Clinical trials in COVID:
PRO: John C Marshall (Toronto, Canada)
CON: Mervyn Singer (London, United Kingdom)
LIFE AFTER INTENSIVE CARE
Peter Pickkers (Nijmegen, Netherlands)
-
-
Quality of life after cardiac arrest
Claudio Sandroni (Rome, Italy)
-
-
Frailty and persistent critical illness
Rinaldo Bellomo (Melbourne, Australia)
-
-
Altered DNA methylation drives PICS
Greet Van den Berghe (Leuven, Belgium)
-
-
What happens to the cirrhotic patient?
Thierry Gustot (Brussels, Belgium)
-
-
Discussion
SHEDDING LIGHT ON ARDS
B Taylor Thompson (Boston, United States)
-
-
ARDS in immunocompromised patients is a specific entity
Alexandre Demoule (Paris, France)
-
-
Pediatric ARDS is also different
Adrienne Randolph (Boston, United States)
-
-
Respiratory subsets: my personal view
Jesus Villar (Las Palmas de Gran Canaria, Spain)
-
-
Discussion
-
-
ARDS subphenotypes: lessons from COVID-19
Lieuwe Bos (Amsterdam, Netherlands)
-
-
Phenotypes are moving closer to clinical trials
Carolyn S Calfee (San Francisco, United States)
-
-
Studying the lung microbiome can help
Massimo Antonelli (Rome, Italy)
-
-
Discussion
-
-
Break
-
-
Corticosteroid administration in ARDS
CON: B Taylor Thompson (Boston, United States)
PRO: Jesus Villar (Las Palmas de Gran Canaria, Spain)
CELLULAR HOMEOSTASIS
Edward Schenck (New York, United States)
-
-
Mitochondrial dysfunction
Arthur van Zanten (Ede, Netherlands)
-
-
Biogenesis
Tim Rahmel (Bochum, Germany)
-
-
Metabolomics
Carolyn S Calfee (San Francisco, United States)
-
-
Lipidomics
Tom van der Poll (Amsterdam, Netherlands)
-
-
Microcirculation
Matthias Hilty (Zurich, Switzerland)
-
-
Discussion
FUTURE SEPSIS THERAPIES
Bruno François (Limoges, France)
-
-
Focus on disease tolerance in sepsis
Christopher Seymour (Pittsburgh, United States)
-
-
More immunoglobulin administration?
Tobias Welte (Hannover, Germany)
-
-
Immune stimulation
Anthony Gordon (London, United Kingdom)
-
-
Discussion
-
-
Extracorporeal immune cell therapy for immune stimulation
Steffen R. Mitzner (Rostock, Germany)
-
-
Checkpoint inhibitors
David Grimaldi (Brussels, Belgium)
-
-
TREM-1 inhibition in septic shock
Sébastien Gibot (Nancy, France)
-
-
Discussion
-
-
Recombinant alkaline phosphatase for renal protection
Peter Pickkers (Nijmegen, Netherlands)
-
-
Targeting coagulation
Julie Helms (Strasbourg, France)
-
-
We will personalize therapies
Lennie Derde (Utrecht, Netherlands)
-
-
Discussion
FLUID RESUSCITATION AND REMOVAL
Jean-Louis Teboul (Le Kremlin-Bicêtre, France)
-
-
Does the concept of liberal vs. restrictive fluid administration make sense?
Nathan Shapiro (Boston, United States)
-
-
The limitations of fluid responsiveness tests
Sheila N Myatra (Mumbai, India)
-
-
Look only at the peripheral perfusion
Jan Bakker (New York, United States)
-
-
Look only at the microcirculation
Jacques Duranteau (Le Kremlin-Bicêtre, France)
-
-
Look at the patient, not at the fluid balance
Daniel De Backer (Braine l´Alleud, Belgium)
-
-
Discussion
NUTRITIONAL MANAGEMENT
Simon Finfer (Newtown, Australia)
-
-
Early starvation may be desirable
Jan Gunst (Leuven, Belgium)
-
-
What happens after ICU discharge?
Elisabeth De Waele (Brussels, Belgium)
-
-
Should the ICU team control post-ICU nutrition?
Arthur van Zanten (Ede, Netherlands)
-
-
How to increase awareness of all caregivers
Jean-Charles Preiser (Brussels, Belgium)
-
-
Discussion
-
-
Pulse oximetry revisited
Tomoko Fujii (Tokyo, Japan)
-
-
PEEP titration: a practical guide
Ewan Goligher (Toronto, Canada)
-
-
Management of cardiogenic shock
Hannah Schaubroeck (Ghent, Belgium)
-
-
Venous return: physiology and applications
Antoine Vieillard–Baron (Boulogne-Billancourt, France)
-
-
Cardiorespiratory failure in liver disease
Julia Wendon (London, United Kingdom)
-
-
COVID-19: a review of pharmacologic management
Craig M Coopersmith (Atlanta, United States)
-
-
Non-invasive respiratory support: what to choose?
Massimo Antonelli (Rome, Italy)
Alexandre Demoule (Paris, France)
Gavin Perkins (Warwick, United Kingdom)
Lise Piquilloud (Lausanne, Switzerland)
FLUID DEESCALATION
Michelle Chew (Linköping, Sweden)
-
-
How I reduce fluid overload
Xavier Monnet (Le Kremlin-Bicêtre, France)
-
-
Fluid deescalation: when and how?
Daniel De Backer (Braine l´Alleud, Belgium)
-
-
It may cause harm
Can Ince (Rotterdam, Netherlands)
-
-
Use of miniaturized systems to remove fluid
Claudio Ronco (Vicenza, Italy)
-
-
Discussion
NUTRITIONAL SUPPORT
Stéphane Gaudry (Bobigny, France)
-
-
Enteral nutrition: my 10 recommendations
Annika Reintam Blaser (Tartu, Estonia)
-
-
More calories?
Adam Deane (Victoria, Australia)
-
-
More amino acids?
Nicholas Heming (Garches, France)
-
-
More micronutrients?
Angelique de Man (Amsterdam, Netherlands)
-
-
Discussion
-
-
Bioimpedance may guide protein dosing
Arthur van Zanten (Ede, Netherlands)
-
-
How the type of food can influence the acute illness
Lioudmila Karnatovskaia (Rochester, United States)
-
-
Blood glucose targets in critically ill patients
Jan Gunst (Leuven, Belgium)
-
-
Glucose control in diabetic patients
Adam Deane (Victoria, Australia)
-
-
Discussion
-
-
Break
HOW TO USE RESOURCES WISELY
Edward Schenck (New York, United States)
-
-
ICU admission after major surgery: is there a survival benefit?
Diamanto Aretha (Patras, Greece)
-
-
Influence of national income on ICU structure and organization
Armand Mekontso Dessap (Créteil, France)
-
-
When even the oxygen supply becomes limited
Janet Diaz (Geneva, Switzerland)
-
-
Discussion
-
-
The frugal intensivist: peripheral i.v. vasopressor use and no arterial line
Paul H Mayo (New York, United States)
-
-
There are simple ways to measure blood pressure correctly
Bernd Saugel (Hamburg, Germany)
-
-
Whatshould we do in the absence of hemodynamic monitoring devices?
Xavier Monnet (Le Kremlin-Bicêtre, France)
-
-
Discussion
-
-
The Swiss Personalized Health Network for sepsis
Thierry Calandra (Lausanne, Switzerland)
-
-
The French sepsis database
Djillali Annane (Garches, France)
-
-
The Amsterdam critical care database
Nicole Juffermans (Amsterdam, Netherlands)
-
-
Discussion
-
-
The Michigan data driven quality improvement
Hallie Prescott (Ann Arbor, United States)
-
-
The Australasian experience
Simon Finfer (Newtown, Australia)
-
-
What can we do with all this data?
Edward Schenck (New York, United States)
-
-
Discussion
-
-
Pancreatitis
Angelique de Man (Amsterdam, Netherlands)
Philippe Montravers (Paris, France)
-
-
ECMO for refractory respiratory failure
Daniel Brodie (Baltimore, United States)
Giacomo Grasselli (Milan, Italy)
-
-
Which monitoring do you need for this patient?
Xavier Monnet (Le Kremlin-Bicêtre, France)
-
-
VA ECMO
Federico Pappalardo (Alessandria, Italy)
Alexander Vlaar (Amsterdam, Netherlands)
-
-
Challenging airways
Audrey De Jong (Montpellier, France)
Sheila N Myatra (Mumbai, India)
-
-
Patient-ventilator asynchronies
Leo Heunks (Rotterdam, Netherlands)
Katerina Vaporidi (Heraklion, Greece)
-
-
Palliative care in the ICU
Jacques Creteur (Brussels, Belgium)
Victoria Metaxa (London, United Kingdom)
-
-
Assessing arterial tone at the bedside
Michael R Pinsky (Pittsburgh, United States)
Jean-Louis Teboul (Le Kremlin-Bicêtre, France)
-
-
Identifying dyssynchrony
Elias N Baedorf Kassis (Boston, United States)
Daniel Talmor (Boston, United States)
-
-
Refractory septic shock
Alain Combes (Paris, France)
Hayley B Gershengorn (Miami, United States)
-
-
How I optimize power at the bedside to avoid VILI
Luciano Gattinoni (Göttingen, Germany)
John J Marini (St Paul, United States)
-
-
Acquired diaphragm dysfunction
Alexandre Demoule (Paris, France)
Ewan Goligher (Toronto, Canada)
-
-
The frail neurological patient
Raimund Helbok (Linz, Austria)
Fabio S Taccone (Brussels, Belgium)
-
-
How I use echocardiography in shock
Paul H Mayo (New York, United States)
Anthony McLean (Sydney, Australia)
Wednesday 22 March 2023
COVID-19: WHAT ALSO APPLIES TO BACTERIAL SEPSIS
Matteo Bassetti (Genoa, Italy)
-
-
What COVID-19 taught us about sepsis
John C Marshall (Toronto, Canada)
-
-
How different from bacterial sepsis?
Djillali Annane (Garches, France)
-
-
Were the thrombocoagulopathic mechanisms different?
Beverley Hunt (London, United Kingdom)
-
-
Discussion
-
-
Were anticoagulation strategies different?
Armand Mekontso Dessap (Créteil, France)
-
-
The role of platelets was interesting
Tom van der Poll (Amsterdam, Netherlands)
-
-
The metabolic response was quite different
Elisabeth De Waele (Brussels, Belgium)
-
-
Discussion
-
-
Was the response of the microcirculation different?
Can Ince (Rotterdam, Netherlands)
-
-
Was the risk of VAP particularly high?
Pedro Povoa (Lisbon, Portugal)
-
-
We could be skeptical about corticosteroids
Daniel Talmor (Boston, United States)
-
-
Discussion
-
-
Anti-TREM-1 approaches are promising
Bruno François (Limoges, France)
-
-
Were secondary infections different?
Jan De Waele (Ghent, Belgium)
-
-
Was the post-COVID syndrome different from PICS?
Carol Hodgson (Melbourne, Australia)
-
-
Discussion
SHEDDING LIGHT ON SEPSIS
Anthony Gordon (London, United Kingdom)
-
-
Metagenomic sequencing in the ICU
Carolyn S Calfee (San Francisco, United States)
-
-
Is sepsis very different in children?
Adrienne Randolph (Boston, United States)
-
-
Adaptive immune system responses during critical illness: all the same?
Manu Shankar–Hari (Edinburgh, United Kingdom)
-
-
Subphenotyping based on organ dysfunction trajectory in sepsis
Edward Schenck (New York, United States)
-
-
Let´s individualize corticosteroid administration
Djillali Annane (Garches, France)
-
-
Discussion
PERSONALIZING THE CHOICE OF IV FLUID
Nathan Shapiro (Boston, United States)
-
-
Saline solutions are not bad: hyperchloremia is
Jean-Louis Vincent (Brussels, Belgium)
-
-
Chloride is a neglected electrolyte
Luciano Gattinoni (Göttingen, Germany)
-
-
What´s in a bag of fluid? Tailoring the fluid to the patient
Mervyn Singer (London, United Kingdom)
-
-
When to give bicarbonate in metabolic acidosis
Tomoko Fujii (Tokyo, Japan)
-
-
Discussion
-
-
Appropriate choices in sepsis
Ricard Ferrer (Barcelona, Spain)
-
-
Why not plasma in sepsis?
Christopher Seymour (Pittsburgh, United States)
-
-
Appropriate choices in neurological disease
Marek Mirski (Baltimore, United States)
-
-
Appropriate choices in liver disease
Julia Wendon (London, United Kingdom)
-
-
Discussion
HEMODYNAMIC MANAGEMENT OF THE NEUROLOGICAL PATIENT
Chiara Robba (Genoa, Italy)
-
-
Ultrasound to study cerebral hemodynamics
Aarti Sarwal (Winston Salem, United States)
-
-
Induced hypertension when needed
Fabio S Taccone (Brussels, Belgium)
-
-
Don´t forget cardiac output!
Geert Meyfroidt (Leuven, Belgium)
-
-
Using cardiac signals can also help
Soojin Park (New York, United States)
-
-
Discussion
ARE OUR SYNDROMES STILL USEFUL?
Manu Shankar–Hari (Edinburgh, United Kingdom)
-
-
Is it time to abandon consensus definitions of ARDS and sepsis?
Gordon Rubenfeld (Toronto, Canada)
-
-
If a better ARDS definition is the answer, what is the question?
V Marco Ranieri (Bologna, Italy)
-
-
We need to expand the ARDS criteria
Oriol Roca (Sabadell, Spain)
-
-
Sepsis subtypes
Christopher Seymour (Pittsburgh, United States)
-
-
Discussion
-
-
Bridging the gap for precision medicine
B Taylor Thompson (Boston, United States)
-
-
Finding the treatable traits in ARDS and sepsis
Nuala Meyer (Philadelphia, United States)
-
-
Let us (re)define critical illness
John C Marshall (Toronto, Canada)
-
-
Let us better define clinical trajectories
Michelle N Gong (New York, United States)
-
-
Discussion
CLINICAL TRIALS
Hallie Prescott (Ann Arbor, United States)
-
-
Many practices are not based on a sound evidence base
Mervyn Singer (London, United Kingdom)
-
-
Problems of randomized controlled trials in ARDS
Jesus Villar (Las Palmas de Gran Canaria, Spain)
-
-
Problems with mortality as an endpoint
Michelle N Gong (New York, United States)
-
-
Novel trial designs should include phenotypes
Christopher Seymour (Pittsburgh, United States)
-
-
Discussion
-
-
ICU trials should be Bayesian
Ewan Goligher (Toronto, Canada)
-
-
Adaptive platform trials for all
Carolyn S Calfee (San Francisco, United States)
-
-
We could consider basket trials
B Taylor Thompson (Boston, United States)
-
-
Discussion
-
-
Global collaboration is the future
John C Marshall (Toronto, Canada)
-
-
Using observational cohort studies to complement clinical trials
Nuala Meyer (Philadelphia, United States)
-
-
Redesigning ICU research: more data science, fewer interventional trials
Mauro Oddo (Lausanne, Switzerland)
-
-
Discussion
-
-
ARDS: time to abandon?
PRO: Luciano Gattinoni (Göttingen, Germany)
CON: Michelle N Gong (New York, United States)
VV ECMO: WHAT WE´VE LEARNED RECENTLY
Luciano Gattinoni (Göttingen, Germany)
-
-
Obesity is not a contraindication
Daniel Brodie (Baltimore, United States)
-
-
Age limits revisited
V Marco Ranieri (Bologna, Italy)
-
-
Consider RV function as well
Antoine Vieillard–Baron (Boulogne-Billancourt, France)
-
-
Discussion
-
-
How we used ECMO for severe COVID-19
Alain Combes (Paris, France)
-
-
There was an interesting evolution in the use of ECMO during COVID-19
Daniel Brodie (Baltimore, United States)
-
-
How ECMO changed outcome during COVID-19
Luigi Camporota (London, United Kingdom)
-
-
ECMO: let´s challenge our current practices
Carol Hodgson (Melbourne, Australia)
-
-
Discussion
-
-
Break
-
-
We should abandon CVP monitoring
PRO: Paul H Mayo (New York, United States)
CON: Jean-Louis Teboul (Le Kremlin-Bicêtre, France)
-
-
We should abandon pragmatic trials
CON: Rinaldo Bellomo (Melbourne, Australia)
PRO: Jean-Louis Vincent (Brussels, Belgium)
DIFFICULT INFECTIONS
Tobias Welte (Hannover, Germany)
-
-
First distinguish bacterial from viral infection
Pierre Hausfater (Paris, France)
-
-
S. aureus infections in the ICU
Sebastian Weis (Jena, Germany)
-
-
Klebsiella is the new threat
Matteo Bassetti (Genoa, Italy)
-
-
Risk stratification of multidrug resistant bacteria
Philippe Montravers (Paris, France)
-
-
What is the real threat from antibiotic resistance?
Liesbet De Bus (Ghent, Belgium)
-
-
Discussion
-
-
Any place for phage therapy?
Maya Hites (Brussels, Belgium)
-
-
How to work closely with the Infectious Disease specialist
Sebastian Weis (Jena, Germany)
-
-
CMV in immunocompetent ICU patients: prevent, treat, or ignore
Gordon Rubenfeld (Toronto, Canada)
-
-
Novel antifungal agents
Thierry Calandra (Lausanne, Switzerland)
-
-
Candida resistance and antifungal stewardship
José-Artur Paiva (Porto, Portugal)
-
-
Discussion
-
-
Vitamins and trace-elements: invisible but vital!
Elisabeth De Waele (Brussels, Belgium)
-
-
The cardiovascular effects of vitamin C
Angelique de Man (Amsterdam, Netherlands)
-
-
Mega-dose vitamin C?
Rinaldo Bellomo (Melbourne, Australia)
-
-
Discussion
-
-
Vitamin B in hypophosphatemia?
Adam Deane (Victoria, Australia)
-
-
Vitamin B3 for renal protection?
Stéphane Gaudry (Bobigny, France)
-
-
When to give vitamin D?
Jean-Charles Preiser (Brussels, Belgium)
-
-
Vitamin D in renal failure?
Marlies Ostermann (London, United Kingdom)
-
-
Discussion
-
-
Break
-
-
Hypophosphatemia should be corrected
PRO: Jean-Charles Preiser (Brussels, Belgium)
CON: Mervyn Singer (London, United Kingdom)
WE SHOULD MONITOR THE MICROCIRCULATION IN THE PERIOPERATIVE PERIOD
-
-
We should monitor the microcirculation in the perioperative period
PRO: Jacques Duranteau (Le Kremlin-Bicêtre, France)
CON: Bernd Saugel (Hamburg, Germany)
-
-
The danger within our body
Evangelos Giamarellos–Bourboulis (Athens, Greece)
-
-
Necroinflammatory cell death in sepsis
Edward Schenck (New York, United States)
-
-
Endotoxin has a hormone-like effect
John C Marshall (Toronto, Canada)
-
-
Discussion
-
-
Host response aberrations in ICU-acquired pneumonia
Tom van der Poll (Amsterdam, Netherlands)
-
-
Myeloid-derived suppressor cells as mediators of immunosuppression
Thierry Calandra (Lausanne, Switzerland)
-
-
The role of mitochondria in the immune response
Anthony McLean (Sydney, Australia)
-
-
Discussion
-
-
Compartmentalization of immune responses
Manu Shankar–Hari (Edinburgh, United Kingdom)
-
-
Sustained inflammation can be associated with mortality
Lieuwe Bos (Amsterdam, Netherlands)
-
-
Disease tolerance as an important concept
Sebastian Weis (Jena, Germany)
-
-
Treating fever? … or normothermia?
Mervyn Singer (London, United Kingdom)
-
-
Discussion
-
-
Intoxications
Heatherlee Bailey (Durham, United States)
-
-
Measure creatinine more frequently
Rinaldo Bellomo (Melbourne, Australia)
-
-
Kidney responses to novel therapeutic strategies
Can Ince (Rotterdam, Netherlands)
-
-
Role of identifying subphenotypes
Marlies Ostermann (London, United Kingdom)
-
-
Management in patients with cirrhosis
Thierry Gustot (Brussels, Belgium)
-
-
Discussion
-
-
The optimal blood pressure for the kidneys
Frank van Haren (Sidney, Australia)
-
-
The best vasopressor for the kidney?
Jacques Duranteau (Le Kremlin-Bicêtre, France)
-
-
Vasopressin could have renal protective effects
Patrick Honoré (Yvoir, Belgium)
-
-
Bicarbonate administration: good or bad?
Lui Forni (Guildford, United Kingdom)
-
-
Discussion
-
-
Ventilator dyssynchrony
Elias N Baedorf Kassis (Boston, United States)
-
-
Drug toxicity in cancer patients
Stephen M Pastores (New York, United States)
-
-
Acute exacerbation of chronic respiratory disease
Tobias Welte (Hannover, Germany)
-
-
Physiological principles
Matthias Hilty (Zurich, Switzerland)
-
-
Selecting the right patients
Ewan Goligher (Toronto, Canada)
-
-
For moderate to severe ARDS
Alain Combes (Paris, France)
-
-
Combination with CRRT in ARDS
V Marco Ranieri (Bologna, Italy)
-
-
Is ECCO2R also good for oxygenation?
Luciano Gattinoni (Göttingen, Germany)
-
-
Discussion
-
-
Break
-
-
Thrombocytopenia in the ICU
Elie Azoulay (Paris, France)
-
-
When to suspect a thrombotic microangiopathy
Achim Jörres (Cologne, Germany)
-
-
Emerging treatment options
Sascha David (Zurich, Switzerland)
-
-
Discussion
-
-
Liver-induced coagulopathies
Julia Wendon (London, United Kingdom)
-
-
Sepsis-induced coagulopathy
Julie Helms (Strasbourg, France)
-
-
Should we give iron to the critically ill?
Nicole Juffermans (Amsterdam, Netherlands)
-
-
A research agenda for hemoncology patients
Elie Azoulay (Paris, France)
-
-
Discussion
-
-
New antibiotics
Tobias Welte (Hannover, Germany)
-
-
How to talk to the media about scientific findings
Craig M Coopersmith (Atlanta, United States)
-
-
Antimicrobial stewardship
Paul Dark (Manchester, United Kingdom)
Jan De Waele (Ghent, Belgium)
Lennie Derde (Utrecht, Netherlands)
José-Artur Paiva (Porto, Portugal)
-
-
Macrophage activation syndrome
Evangelos Giamarellos–Bourboulis (Athens, Greece)
-
-
ECPR: when, where, how and for whom?
Jan Belohlavek (Prague, Czech Republic)
Daniel De Backer (Braine l´Alleud, Belgium)
Claudio Sandroni (Rome, Italy)
Leen Vercaemst (Leuven, Belgium)
-
-
How to cope with ICU burnout?
Daniel Brodie (Baltimore, United States)
Sheila N Myatra (Mumbai, India)
Stephen M Pastores (New York, United States)
Fabio S Taccone (Brussels, Belgium)
-
-
Dyspnea in mechanically ventilated patients
Alexandre Demoule (Paris, France)
-
-
Coma
Raimund Helbok (Linz, Austria)
-
-
Hemodynamic monitoring techniques
Xavier Monnet (Le Kremlin-Bicêtre, France)
-
-
Advanced respiratory monitoring
Lise Piquilloud (Lausanne, Switzerland)
-
-
What temperature after cardiac arrest?
Jerry Nolan (Bath, United Kingdom)
Chiara Robba (Genoa, Italy)
Claudio Sandroni (Rome, Italy)
Markus Skrifvars (Helsinki, Finland)
ARTIFICIAL INTELLIGENCE IN THE ICU
Marek Mirski (Baltimore, United States)
-
-
The future is bright
Vincent Liu (Oakland, United States)
-
-
… but artificial intelligence has a dark side
Jan De Waele (Ghent, Belgium)
-
-
… and it´s not smart if it doesn´t improve outcomes
Michelle N Gong (New York, United States)
-
-
Discussion
-
-
Machine learning can identify subphenotypes
Edward Schenck (New York, United States)
-
-
How AI can prevent hemodynamic crises
Alexander Vlaar (Amsterdam, Netherlands)
-
-
How it may improve hemodynamic management
Michael R Pinsky (Pittsburgh, United States)
-
-
Discussion
-
-
How it can analyze microcirculatory alterations
Matthias Hilty (Zurich, Switzerland)
-
-
How it may predict cerebral complications
Soojin Park (New York, United States)
-
-
How it may predict coma recovery
Mauro Oddo (Lausanne, Switzerland)
-
-
Developing further prediction models
Vincent Liu (Oakland, United States)
-
-
Discussion
-
-
Coagulopathies
Julie Helms (Strasbourg, France)
WEANING FROM MECHANICAL VENTILATION
Armand Mekontso Dessap (Créteil, France)
-
-
What is complicated weaning?
Lise Piquilloud (Lausanne, Switzerland)
-
-
How to assess muscle strength
Alexandre Demoule (Paris, France)
-
-
When, where and how to extubate?
Audrey De Jong (Montpellier, France)
-
-
Discussion
-
-
Non-traditional risk factors for failed extubation
Hayley B Gershengorn (Miami, United States)
-
-
How to optimize weaning in children
Adrienne Randolph (Boston, United States)
-
-
Extubation failure in neurological patient
Chiara Robba (Genoa, Italy)
-
-
Non-invasive ventilation to support the weaning process
Gavin Perkins (Warwick, United Kingdom)
-
-
Discussion
-
-
ECMO: things to remember
Leen Vercaemst (Leuven, Belgium)
IMPROVING VASOPRESSOR USE
Xavier Monnet (Le Kremlin-Bicêtre, France)
-
-
When is the radial artery pressure unreliable?
André Denault (Montreal, Canada)
-
-
The peripheral i.v. route is acceptable
Hallie Prescott (Ann Arbor, United States)
-
-
Norepinephrine infusion should be started early
Jean-Louis Teboul (Le Kremlin-Bicêtre, France)
-
-
How to promote veno-constriction
Daniel De Backer (Braine l´Alleud, Belgium)
-
-
Discussion
-
-
Starting with vasopressin?
Diamanto Aretha (Patras, Greece)
-
-
New vasopressors, new evidence
Ashish K Khanna (Winston-Salem, United States)
-
-
Angiotensin II has additional properties
Rinaldo Bellomo (Melbourne, Australia)
-
-
Discussion
-
-
The vasopressor test
Jan Bakker (New York, United States)
-
-
Combination therapies in septic shock: when and how?
Sharon Einav (Jerusalem, Israel)
-
-
When to add an inotropic agent?
Michelle Chew (Linköping, Sweden)
-
-
Discussion
-
-
… or a beta blocker?
Vasileios Papaioannou (Alexandroupolis, Greece)
-
-
Continuing controversies
Hannah Wunsch (Toronto, Canada)
-
-
What do we mean by ´refractory` septic shock?
Ricard Ferrer (Barcelona, Spain)
-
-
Discussion
-
-
Cardiac arrest guidelines
Gavin Perkins (Warwick, United Kingdom)
RENAL REPLACEMENT THERAPY
Steffen R. Mitzner (Rostock, Germany)
-
-
Diffusion, convection, adsorption: what´s best?
Claudio Ronco (Vicenza, Italy)
-
-
Can we predict who will need RRT?
Lui Forni (Guildford, United Kingdom)
-
-
How the choice may influence recovery
Rinaldo Bellomo (Melbourne, Australia)
-
-
Discussion
-
-
CVVHD is so much better than CVVH
Xose L Pérez Fernández (Bueu, Spain)
-
-
How to effectively prolong CRRT filter life
Tomoko Fujii (Tokyo, Japan)
-
-
Regional citrate anticoagulation
Joop Jonckheer (Brussels, Belgium)
-
-
How to reduce the risk of RRT-induced kidney injury
Stéphane Gaudry (Bobigny, France)
-
-
Discussion
-
-
Optimal fluid management
Marlies Ostermann (London, United Kingdom)
-
-
Optimal feeding
Joop Jonckheer (Brussels, Belgium)
-
-
When to stop
Achim Jörres (Cologne, Germany)
-
-
The remaining questions
Dmytro Khadzhynov (Berlin, Germany)
-
-
Discussion
-
-
A case of diarrhea
Annika Reintam Blaser (Tartu, Estonia)
-
-
Advancing sedation strategies
Michael Reade (Brisbane, Australia)
Yahya Shehabi (Clayton, Australia)
-
-
Non-invasive ventilatory support
Massimo Antonelli (Rome, Italy)
Lise Piquilloud (Lausanne, Switzerland)
-
-
Blood purification techniques
Gabriella Bottari (Rome, Italy)
Claudio Ronco (Vicenza, Italy)
-
-
Monitoring respiratory mechanics, drive, and effort
Giacomo Grasselli (Milan, Italy)
Leo Heunks (Rotterdam, Netherlands)
-
-
CAR-T toxicity
Victoria Metaxa (London, United Kingdom)
-
-
Management of thoracic trauma
Jacques Duranteau (Le Kremlin-Bicêtre, France)
Marc Maegele (Cologne, Germany)
-
-
Non-resolving conflicts with relatives
Elie Azoulay (Paris, France)
Victoria Metaxa (London, United Kingdom)
-
-
Refeeding syndrome
Annika Reintam Blaser (Tartu, Estonia)
Arthur van Zanten (Ede, Netherlands)
-
-
Transesophageal lung ultrasonography
Daniel De Backer (Braine l´Alleud, Belgium)
Paul H Mayo (New York, United States)
-
-
Lung recruitment
Laurent Brochard (Toronto, Canada)
John J Marini (St Paul, United States)
-
-
Coagulopathy: differential diagnosis
Elie Azoulay (Paris, France)
-
-
Antibiotic prophylaxis in patients colonized with MDR bacteria
Philippe Montravers (Paris, France)
Pedro Povoa (Lisbon, Portugal)
-
-
Massive bleeding
Nicole Juffermans (Amsterdam, Netherlands)
Marc Maegele (Cologne, Germany)
-
-
Critical care echocardiography
Anthony McLean (Sydney, Australia)
Susanna Price (London, United Kingdom)
-
-
Vasopressor management in septic shock
Arthur van Zanten (Ede, Netherlands)
-
-
Advanced hemodynamic monitoring in the ICU
Alexander Vlaar (Amsterdam, Netherlands)
-
-
How to use TTM after cardiac arrest?
Rinaldo Bellomo (Melbourne, Australia)
Jerry Nolan (Bath, United Kingdom)
-
-
Are you awake? Are you conscious?
Jan Claassen (New York, United States)
Jacques Duranteau (Le Kremlin-Bicêtre, France)
-
-
Analgesia and sedation strategies for neurological patients
Pierre Bouzat (Grenoble, France)
Marek Mirski (Baltimore, United States)
-
-
The patient who bleeds but needs anticoagulants
Julie Helms (Strasbourg, France)
Beverley Hunt (London, United Kingdom)
-
-
Interstitial lung diseases
Angelique de Man (Amsterdam, Netherlands)
Janet Diaz (Geneva, Switzerland)
Thursday 23 March 2023
PANDEMICS: THE BIG PICTURE
Yahya Shehabi (Clayton, Australia)
-
-
From polio to COVID-19
Hannah Wunsch (Toronto, Canada)
-
-
What infectious diseases are emerging?
Janet Diaz (Geneva, Switzerland)
-
-
How research reshaped practice
Djillali Annane (Garches, France)
-
-
Discussion
-
-
There is a need for ´frugal innovation`
Armand Mekontso Dessap (Créteil, France)
-
-
How social media broke science
Gordon Rubenfeld (Toronto, Canada)
-
-
Anticipating the next pandemic: resilience is the key
Lennie Derde (Utrecht, Netherlands)
-
-
Discussion
-
-
POSTER AWARDS